The ketogenic diet added to usual care may offer a small benefit for treatment-resistant depression, the authors concluded.

Once-weekly subcutaneous tirzepatide may not raise risk for depression compared with placebo, according to a post hoc analysis of the SURMOUNT trials. As Healio previously reported, in January the FDA ...

Have you experienced any depressive symptoms over the past two weeks? Do you think you could be suffering from clinical depression? If so, you might want to consider filling out a brief Patient Health ...

Fitzpatrick is a behavioral health care quality manager at Epic Systems. Engel, M.D., Ph.D., is a recent graduate of Harvard Medical School and a first-year psychiatry resident at Stanford. Boyd, M.D.